LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ)

CUSIP: 52635N103

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
31,378,962
Total 13F shares
18,735,645
Share change
-134,092
Total reported value
$444,795,067
Price per share
$23.74
Number of holders
78
Value change
-$1,423,016
Number of buys
41
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 52635N103?
CUSIP 52635N103 identifies LENZ - LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ) as of Q3 2024

As of 30 Sep 2024, LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,735,645 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Alpha Wave Global, LP, Samsara BioCapital, LLC, VANGUARD GROUP INC, 72 Investment Holdings, LLC, SECTORAL ASSET MANAGEMENT INC, BlackRock, Inc., Point72 Asset Management, L.P., RTW INVESTMENTS, LP, and TANG CAPITAL MANAGEMENT LLC. This page lists 78 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.